Race Oncology's (ASX:RAC) RC220 bisantrene has received FDA orphan drug designation for leukaemia treatment.

Bapcor (ASX:BAP) has confirmed a $1.83B takeover offer from Bain Capital.

And Swoop (ASX:SWP) is selling its wholesale voice business to Pivotel Group for $9M.